Phosphatidylserine-positive extracellular vesicles boost effector CD8<sup>+</sup> T cell responses during viral infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37040405.
- Also identified by DOI 10.1073/pnas.2210047120 and PMC identifier 10120060.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CD8<sup>+</sup> T cells are crucial for the clearance of viral infections. During the acute phase, proinflammatory conditions increase the amount of circulating phosphatidylserine<sup>+</sup> (PS) extracellular vesicles (EVs). These EVs interact especially with CD8<sup>+</sup> T cells; however, it remains unclear whether they can actively modulate CD8<sup>+</sup> T cell responses. In this study, we have developed a method to analyze cell-bound PS<sup>+</sup> EVs and their target cells in vivo. We show that EV<sup>+</sup> cell abundance increases during viral infection and that EVs preferentially bind to activated, but not naive, CD8<sup>+</sup> T cells. Superresolution imaging revealed that PS<sup>+</sup> EVs attach to clusters of CD8 molecules on the T cell surface. Furthermore, EV-binding induces antigen (Ag)-specific TCR signaling and increased nuclear translocation of the transcription factor Nuclear factor of activated T-cells (NFATc1) in vivo. EV-decorated but not EV-free CD8<sup>+</sup> T cells are enriched for gene signatures associated with T-cell receptor signaling, early effector differentiation, and proliferation. Our data thus demonstrate that PS<sup>+</sup> EVs provide Ag-specific adjuvant effects to activated CD8<sup>+</sup> T cells in vivo.
Medical subject headings
- Extracellular Vesicles
- Virus Diseases